Who owns AbCellera Biologics Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ABCL from SEC Form 13F filings across 164 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 164 institutions disclosed 131.2M shares of AbCellera Biologics Inc. worth $1.90B — about 41.2% of shares outstanding; the largest disclosed holder is BAKER BROS. ADVISORS LP. Source: SEC Form 13F filings, parsed by EvidInvest.
164
13F holders
$1.90B
value, 2026 filers
41.2%
of shares outstanding (131.2M sh)
45
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of ABCL's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BAKER BROS. ADVISORS LP | 33.0M | $481.6M | 2.3% | 10.4% | 0.0% |
| 2 | Capital World Investors | 13.6M | $198.1M | 0.0% | 4.3% | -0.1% |
| 3 | TWO SIGMA INVESTMENTS, LP | 11.7M | $170.7M | 0.1% | 3.7% | +12.1% |
| 4 | TD Waterhouse Canada Inc. | 9.2M | $128.3M | 0.3% | 2.9% | -3.6% |
| 5 | MARSHALL WACE, LLP | 9.0M | $130.7M | 0.1% | 2.8% | +370.9% |
| 6 | BlackRock, Inc. | 5.7M | $82.6M | 0.0% | 1.8% | +48.8% |
| 7 | ArrowMark Colorado Holdings LLC | 4.8M | $70.4M | 3.3% | 1.5% | +17.5% |
| 8 | BANK OF AMERICA CORP /DE/ | 4.2M | $61.0M | 0.0% | 1.3% | -31.9% |
| 9 | D. E. Shaw & Co., Inc. | 3.7M | $53.4M | 0.0% | 1.2% | +7952.5% |
| 10 | Alyeska Investment Group, L.P. | 3.1M | $44.7M | 0.1% | 1% | +481.9% |
| 11 | Driehaus Capital Management LLC | 2.8M | $41.4M | 0.3% | 0.9% | -1.0% |
| 12 | MILLENNIUM MANAGEMENT LLC | 2.0M | $29.7M | 0.0% | 0.6% | +293.0% |
| 13 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2.0M | $29.4M | 0.0% | 0.6% | +93.6% |
| 14 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1.8M | $26.4M | 0.0% | 0.6% | -58.0% |
| 15 | FRANKLIN TEMPLETON INCNEW | 1.5M | $18.9M | 0.0% | 0.5% | new |
| 16 | JANE STREET GROUP, LLC | 1.5M | $22.1M | 0.0% | 0.5% | +674.9% |
| 17 | AMERICAN CENTURY COMPANIES INC | 1.3M | $18.5M | 0.0% | 0.4% | +1064.2% |
| 18 | NATIONAL BANK OF CANADA /FI/ | 1.1M | $16.4M | 0.0% | 0.4% | -9.0% |
| 19 | TUDOR INVESTMENT CORP ET AL | 913,226 | $13.3M | 0.0% | 0.3% | -55.7% |
| 20 | MORGAN STANLEY | 855,650 | $12.5M | 0.0% | 0.3% | -48.7% |
| 21 | GOLDMAN SACHS GROUP INC | 837,416 | $12.2M | 0.0% | 0.3% | +256.2% |
| 22 | ADAR1 Capital Management, LLCNEW | 822,163 | $12.0M | 0.5% | 0.3% | new |
| 23 | CITADEL ADVISORS LLC | 795,856 | $11.6M | 0.0% | 0.3% | -49.8% |
| 24 | Trexquant Investment LPNEW | 786,276 | $11.5M | 0.1% | 0.2% | new |
| 25 | DNB ASSET MANAGEMENT AS | 685,513 | $10.0M | 0.0% | 0.2% | +1.2% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.